NEWARK, Del, June 26, 2024 (GLOBE NEWSWIRE) -- The IV therapy and vein access devices market is expected to reach USD 28.7 billion by 2024. From 2024 to 2034, revenue is expected to increase by 5.1% ...

Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access Market" report has been added to ResearchAndMarkets.com's offering. The global market for IV therapy and venous ...

A simple reversal of the way a long-standing surgical procedure is performed to create an arteriovenous fistula for hemodialysis access significantly improves the fistula's function and longevity over ...

Axillary vein access has emerged as a safe and efficient alternative for cardiac device implantation. By utilising the anatomical course of the axillary vein, clinicians can facilitate the insertion ...

Argon Medical Devices — a manufacturer of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology — recently introduced its Traveler Portal ...

Countless patients at East Lancashire Hospitals NHS Trust (ELHT) will benefit from a new piece of equipment made possible ...

The MarketWatch News Department was not involved in the creation of this content. "Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly ...

Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

Soffer Health unveils redesigned website to improve access to vein treatment and cardiology services. Our new website ...